Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Loss of appetite: due to the mechanisms of action, loss of appetite is also a common side effect
IV L-carnitine is also approved for the treatment of carnitine deficiency resulting from dialysis in patients with end-stage renal disease
Targeting this AKT1-PRMT7-GLUD1 axis with SGC3027 enhances the therapeutic response to DTX, providing a novel combinatorial therapy for gastric cancer
Pregnant or breastfeeding patients should consult a doctor before receiving IV therapy
Our data show that in mice intestinal barrier function is impaired before the clinical onset of arthritis, while in humans serum markers associated with impaired intestinal barrier function are also increased before the onset of RA and associated with a higher risk to develop RA later on
US$ 24.18
US$ 28.38
US$ 24.72
US$ 28.30
US$ 25.64
